RBC Life SciencesRBCL 
$0.000.00%24h
0.00%24h
Global rank
Market cap$154.91
Change 7d-
YTD Performance-30.00%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Consumer Defensive
Category
Market capitalization of RBC Life Sciences (RBCL)
As of September 2024, RBC Life Sciences has a market cap of $154.91. This makes RBC Life Sciences the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of RBC Life Sciences from 1996 to 2024
-
Value:-
Market cap history of RBC Life Sciences from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $221.30 | 0.00% |
| 2023 | $221.30 | -99.23% |
| 2022 | $28.77K | 3150.00% |
| 2021 | $885.20 | -99.80% |
| 2020 | $442.60K | 244.83% |
| 2019 | $128.35K | -72.90% |
| 2018 | $473.69K | -28.65% |
| 2017 | $663.90K | 0.00% |
| 2016 | $663.90K | 20.00% |
| 2015 | $553.25K | -80.77% |
| 2014 | $2.88M | -16.13% |
| 2013 | $3.43M | 55.00% |
| 2012 | $2.21M | -50.00% |
| 2011 | $4.43M | -28.57% |
| 2010 | $6.20M | 30.23% |
| 2009 | $4.76M | -59.36% |
| 2008 | $11.71M | -35.49% |
| 2007 | $18.15M | 290.48% |
| 2006 | $4.65M | -71.62% |
| 2005 | $16.38M | 311.11% |
| 2004 | $3.98M | -56.10% |
| 2003 | $9.07M | 485.71% |
| 2002 | $1.55M | -50.00% |
| 2001 | $3.10M | -65.52% |
| 2000 | $8.98M | -42.26% |
| 1999 | $15.56M | -37.50% |
| 1998 | $24.90M | 50.00% |
| 1997 | $16.60M | -42.86% |
| 1996 | $29.05M | - |
RBCL Market Cap Today is $154.91 0.00% - 26 Sept 2024
View largest stocks by market cap 
